0%, 100%, then 200%: How Trump's new generic drug tariff plan could hit India

Donald Trump announced phased tariffs on imported generic medicines starting August 2026. These tariffs will gradually increase to 200 percent over three years. This policy aims to reshore pharmaceutical production back into America. India, a major supplier of affordable generics, faces significa...

First seen 48m ago · latest update 48m ago · India · politics

Developing: this story surfaced recently from a single outlet. It appears early by design — expect the confidence score to move as more outlets report (or don’t).